In line with these in vitro observations, CD151 knockdown extended the survival of tumor-bearing mice with orthotopic LN229 glioblastoma xenografts (Fig. 2D, p < 0.05), even though minimal change occurred in tumor growth. This evidence concerns the gene CD151 and neoplasm.